可吸收手术缝线市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球可吸收手术缝线市场规模达30亿美元，预计2034年将以5.6%的复合年增长率成长，达到52亿美元。市场成长的驱动力包括全球外科手术数量的急剧上升、慢性病发病率的上升、缝合技术的进步以及妇科手术数量的激增。随着医疗保健系统更加重视微创技术、更快的復原时间和更佳的患者预后，可吸收缝线的需求也不断增长。材料和技术的持续改进，包括涂层和线结构的创新，正在全球医院、外科中心和门诊机构中扩大可吸收缝线的使用率方面发挥着重要作用。

可吸收手术缝线旨在体内自然分解，无需手动拆除，并简化术后护理。其抗菌性能、倒钩线结构和高性能聚合物共混物等增强特性有助于降低感染风险并加速癒合。随着越来越多的临床实践采用这些先进的工具，整体效率和患者体验得到提升，进一步增强了该产品在现代医疗保健中的相关性。对患者舒适度和手术优化的日益关注，使可吸收缝合线成为多个外科专业的首选。

2024年，合成缝合线市场占71.4%的市场份额，这得益于其可靠的吸收特性、高强度维持性和较低的生物反应性。聚二噁烷酮(PDO)、聚乳酸(PLA)和聚乙醇酸(PGA)等材料能够帮助外科医生精确控制降解时间，从而在伤口癒合的每个阶段提供个人化支持。它们在开放性手术和微创手术中的适应性使其成为高精度环境中值得信赖的解决方案。

2024年，医院板块占据了55.2%的市场。这种主导地位与医院基础设施的扩张（尤其是在高成长国家）、慢性病负担的增加以及外科技术可近性的提高息息相关。随着医疗体系的不断发展，新建和现有医院都优先考虑先进的缝合技术，以改善疗效、降低併发症发生率并满足现代外科标准。

2024年，美国可吸收手术缝线市场规模达11亿美元。慢性病的增多以及对先进外科护理的需求持续推高了市场需求。随着每年心血管、肿瘤和一般手术数量的不断增长，人们越来越倾向于选择能够促进快速康復、降低感染风险并透过自然吸收最大程度减轻患者不适的缝线。

全球可吸收手术缝合线市场的主要参与者包括 Demetech、Corza Medical、Futura Surgicare、B. Braun、美敦力、Unisur、Vitrex Medical Group、Healthium Medtech、Genesis MedTech、Vital Sutures、Advanced Medical Solutions、Lotus Surgicals、Integra Lifesciences、强生和 CONMEDs。可吸收手术缝线市场中的公司正透过生物材料设计和抗菌技术的创新来巩固其市场地位。各公司正专注于研发具有更高抗拉强度、可控降解速率且与微创技术相容的缝合线。公司正在积极进行併购和策略合作，以扩大产品组合和全球影响力。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 慢性病盛行率不断上升
    • 全球范围内外科手术数量不断增加
    • 缝合材料的进步
    • 妇科手术数量不断增加
  • 产业陷阱与挑战
    • 手术费用高昂
    • 严格的监管框架
  • 市场机会
    • 微创手术的需求不断增长
• 成长潜力分析
• 监管格局
  • 北美洲
  • 欧洲
  • 亚太地区
• 技术进步
  • 当前的技术趋势
  • 新兴技术
• 供应链分析
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 自然缝合
• 合成缝合线
  • Vicryl
  • 聚对二氧环己酮缝合线（PDS）
  • 聚卡普龙缝合线（Monocryl）

第六章：市场估计与预测：依结构，2021 - 2034 年

• 主要趋势
• 单丝
• 复丝

第七章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 心血管外科
• 妇科手术
• 骨科手术
• 眼科手术
• 神经外科
• 其他外科手术应用

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 专科诊所
• 门诊手术中心
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第十章：公司简介

• Advanced Medical Solutions
• B. Braun
• Corza Medical
• CONMED
• Demetech
• Futura Surgicare
• Genesis MedTech
• Healthium Medtech
• Integra Lifesciences
• Johnson & Johnson
• Medtronic
• Lotus Surgicals
• Unisur
• Vital Sutures
• Vitrex Medical Group

The Global Absorbable Surgical Sutures Market was valued at USD 3 billion in 2024 and is estimated to grow at a CAGR of 5.6% to reach USD 5.2 billion by 2034. Market growth is being driven by a sharp rise in the number of surgical procedures worldwide, increasing incidences of chronic illnesses, advancements in suture technology, and a surge in gynecological surgeries. The demand for absorbable sutures is also growing as healthcare systems focus more on minimally invasive techniques, faster recovery timelines, and improved patient outcomes. Continuous improvements in materials and technologies, including innovations in coatings and thread structures, are playing a major role in expanding usage across hospitals, surgical centers, and outpatient facilities globally.

Absorbable surgical sutures are designed to naturally break down within the body, removing the need for manual removal and simplifying postoperative care. Enhanced features such as antimicrobial properties, barbed thread structures, and high-performance polymer blends are helping reduce infection risks and accelerate healing. As more clinical practices adopt these advanced tools, the overall efficiency and patient experience improve, reinforcing the product's relevance in modern healthcare. Increasing focus on patient comfort and procedure optimization is positioning absorbable sutures as a preferred choice across multiple surgical specialties.

The synthetic sutures segment held 71.4% share in 2024, supported by their reliable absorption profiles, high strength retention, and reduced biological reactivity. Materials like polydioxanone (PDO), polylactic acid (PLA), and polyglycolic acid (PGA) offer surgeons precise control over degradation timelines, allowing tailored support during each phase of wound healing. Their adaptability in both open and minimally invasive procedures makes them a trusted solution in high-precision environments.

The hospitals segment held a 55.2% share in 2024. This dominance is linked to expanding hospital infrastructure, especially in high-growth countries, alongside rising chronic disease burdens and enhanced access to surgical technologies. As healthcare systems evolve, newly built and existing hospitals are prioritizing advanced suturing options to improve outcomes, reduce complication rates, and meet modern surgical standards.

United States Absorbable Surgical Sutures Market generated USD 1.1 billion in 2024. Rising chronic conditions and the need for advanced surgical care continue to elevate demand. With a growing number of cardiovascular, oncological, and general surgeries performed annually, there's a strong shift toward sutures that promote faster recovery, lower infection risks, and minimize patient discomfort through natural absorption.

Key players dominating the Global Absorbable Surgical Sutures Market include Demetech, Corza Medical, Futura Surgicare, B. Braun, Medtronic, Unisur, Vitrex Medical Group, Healthium Medtech, Genesis MedTech, Vital Sutures, Advanced Medical Solutions, Lotus Surgicals, Integra Lifesciences, Johnson & Johnson, and CONMED. Companies operating in the absorbable surgical sutures market are strengthening their positions through innovation in biomaterial design and antimicrobial technologies. Firms are focusing on R&D to develop sutures with enhanced tensile strength, controlled degradation rates, and compatibility with minimally invasive techniques. Mergers, acquisitions, and strategic collaborations are being pursued to expand product portfolios and global reach.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Material trends
  • 2.2.3 Structure trends
  • 2.2.4 Application trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic diseases
    • 3.2.1.2 Rising surgical procedures worldwide
    • 3.2.1.3 Advancements in suture materials
    • 3.2.1.4 Increasing number of gynecological procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of procedures
    • 3.2.2.2 Stringent regulatory framework
  • 3.2.3 Market opportunities
    • 3.2.3.1 Growing demand for minimally invasive surgeries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Supply chain analysis
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Natural suture
• 5.3 Synthetic suture
  • 5.3.1 Vicryl
  • 5.3.2 Polydioxanone suture (PDS)
  • 5.3.3 Poliglecaprone suture (Monocryl)

Chapter 6 Market Estimates and Forecast, By Structure, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Monofilament
• 6.3 Multifilament

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Cardiovascular surgery
• 7.3 Gynaecology surgery
• 7.4 Orthopaedic surgery
• 7.5 Ophthalmic surgery
• 7.6 Neurological surgery
• 7.7 Other surgical applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Specialty clinics
• 8.4 Ambulatory surgical centres
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Advanced Medical Solutions
• 10.2 B. Braun
• 10.3 Corza Medical
• 10.4 CONMED
• 10.5 Demetech
• 10.6 Futura Surgicare
• 10.7 Genesis MedTech
• 10.8 Healthium Medtech
• 10.9 Integra Lifesciences
• 10.10 Johnson & Johnson
• 10.11 Medtronic
• 10.12 Lotus Surgicals
• 10.13 Unisur
• 10.14 Vital Sutures
• 10.15 Vitrex Medical Group